Gene: TBCCD1
Official Full Name: TBCC domain containing 1provided by HGNC
Gene Summary: Involved in several processes, including maintenance of Golgi location; maintenance of centrosome location; and regulation of cell shape. Located in spindle pole centrosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13527 | TBCCD1 Knockout cell line (HeLa) | Human | TBCCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO13528 | TBCCD1 Knockout cell line (HCT 116) | Human | TBCCD1 | 1:2~1:4 | Negative | Online Inquiry |
KO13529 | TBCCD1 Knockout cell line (HEK293) | Human | TBCCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO13530 | TBCCD1 Knockout cell line (A549) | Human | TBCCD1 | 1:3~1:4 | Negative | Online Inquiry |
TBCCD1 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the TBCCD1 gene and its associated pathways. These cell lines are generated through targeted gene editing techniques, such as CRISPR/Cas9, effectively disrupting the TBCCD1 gene to elucidate its function in cellular processes. The TBCCD1 gene has been implicated in crucial cellular functions, including cell cycle regulation and apoptosis, making knockout models invaluable for dissecting these biological pathways.
The key mechanism behind the use of TBCCD1 Gene Knockout Cell Lines lies in their ability to mimic the loss-of-function mutations found in various diseases. By studying these knockout models, researchers can gain insights into the pathophysiology of conditions such as cancer and neurodegenerative disorders, thus advancing our understanding of disease mechanisms. Additionally, these cell lines serve as powerful tools for drug screening, allowing for the identification of compounds that may restore normal function or induce cell death in TBCCD1-deficient cells.
The scientific significance of these knockout cell lines extends to both basic research and clinical applications, including the development of targeted therapies. Their capacity to provide a more accurate representation of the biologically relevant conditions allows researchers and clinicians to develop more effective therapeutic strategies compared to traditional models.
A primary advantage of TBCCD1 Gene Knockout Cell Lines is their specificity and reliability; they provide a controlled environment where the effects of the TBCCD1 gene can be studied without the confounding influences often present in non-targeted models. This specificity enhances the reproducibility of experiments, leading to more reliable outcomes and interpretations.
For researchers and clinicians, leveraging TBCCD1 Gene Knockout Cell Lines translates to a profound opportunity to advance the frontiers of molecular biology and therapeutic development. By utilizing these advanced models, professionals are better equipped to uncover novel insights and innovations within their fields.
Our company specializes in providing high-quality biological research tools, underpinned by a commitment to scientific excellence and innovation. With our expertise in gene editing and cellular biology, we are dedicated to supporting researchers in their quest for knowledge and therapeutic breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.